Immunic Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | +484,366.0% | -98.5% | +233.3% | -22.0% | +117.9% | -9.4% | +44.2% | +20.7% | +25.4% | |
| – | – | – | -17,324.7% | – | – | – | – | – | – | – | – | |
| – | +0.7% | -24.5% | +30.9% | -36.9% | -9.3% | +71.6% | +58.2% | +16.6% | +16.8% | -3.8% | +2.4% | |
| – | +13.7% | -9.1% | +18.7% | +2.0% | +6.9% | -28.8% | +28.7% | +14.8% | +4.9% | +12.5% | +18.0% | |
| – | +3.5% | -20.8% | +27.6% | -27.1% | -3.6% | +32.2% | +87.2% | +30.4% | -17.0% | -1.2% | +5.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -45.8% | +46.6% | +1,124.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -119.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.